Vitamin D3 to Treat COVID-19: Different Disease, Same Answer.
作者信息
Leaf David E, Ginde Adit A
机构信息
Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Department of Emergency Medicine, University of Colorado School of Medicine, Aurora.
出版信息
JAMA. 2021 Mar 16;325(11):1047-1048. doi: 10.1001/jama.2020.26850.
Abstract
摘要
相似文献
1
Vitamin D3 to Treat COVID-19: Different Disease, Same Answer.维生素D3治疗新冠肺炎：疾病不同，答案相同。
JAMA. 2021 Mar 16;325(11):1047-1048. doi: 10.1001/jama.2020.26850.
2
Learning from previous methodological pitfalls to propose well-designed trials on vitamin D in COVID-19.从以往的方法学缺陷中吸取教训，以提出关于维生素D在2019冠状病毒病（COVID-19）治疗中设计完善的试验。
J Steroid Biochem Mol Biol. 2021 Jul;211:105901. doi: 10.1016/j.jsbmb.2021.105901. Epub 2021 Apr 14.
3
Vitamin D (Cholecalciferol) with Low Dose Vitamin C as a Safe and Effective Therapeutic Modality in an Adult with COVID-19 Pneumonia.维生素 D（胆钙化醇）联合小剂量维生素 C 作为 COVID-19 肺炎成人患者安全有效的治疗方法。
J Coll Physicians Surg Pak. 2021 Jan;31(1):S90-S92. doi: 10.29271/jcpsp.2021.Supp3.S90.
4
Bad Prognosis in Critical Ill Patients with COVID-19 during Short-Term ICU Stay regarding Vitamin D Levels.危重症 COVID-19 患者短期 ICU 期间维生素 D 水平与预后不良相关。
Nutrients. 2021 Jun 9;13(6):1988. doi: 10.3390/nu13061988.
5
Vitamin D and Wellbeing beyond Infections: COVID-19 and Future Pandemics.维生素D与感染之外的健康：新冠疫情及未来大流行
J Am Coll Nutr. 2021 Jan;40(1):41-42. doi: 10.1080/07315724.2020.1786302. Epub 2020 Aug 14.
6
Vitamin D Levels Are Reduced at the Time of Hospital Admission in Sicilian SARS-CoV-2-Positive Patients.西西里 SARS-CoV-2 阳性患者住院时维生素 D 水平降低。
Int J Environ Res Public Health. 2021 Mar 27;18(7):3491. doi: 10.3390/ijerph18073491.
7
[Vitamin D and coronavirus: a new field of use?].[维生素D与冠状病毒：一个新的应用领域？]
Recenti Prog Med. 2020 Apr;111(4):253-256. doi: 10.1701/3347.33188.
8
Vitamin D, SARS-CoV-2 and Causal Associations in Transversal Studies: The Time-Series Analysis to Reveal Potential Confounders. Comment on Gaudio et al. Vitamin D Levels Are Reduced at the Time of Hospital Admission in Sicilian SARS-CoV-2-Positive Patients. 2021, , 3491.维生素 D、SARS-CoV-2 与横断面研究中的因果关系：时间序列分析揭示潜在混杂因素。评 Gaudio 等人的文章《西西里 SARS-CoV-2 阳性患者住院时维生素 D 水平降低》。2021,, 3491.
Int J Environ Res Public Health. 2021 Jun 24;18(13):6793. doi: 10.3390/ijerph18136793.
9
Vitamin D Sufficiency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link?维生素D充足与2019冠状病毒病：维生素D结合蛋白（及其多态性）是缺失的环节吗？
Endocr Pract. 2021 Jun;27(6):645. doi: 10.1016/j.eprac.2021.03.011. Epub 2021 Apr 2.
10
Importance of the Lipid-Bound Character of Vitamin D Binding Protein in the Evaluation of Vitamin D Status in COVID-19 Patients.维生素D结合蛋白的脂质结合特性在评估COVID-19患者维生素D状态中的重要性。
Am J Clin Pathol. 2021 Apr 26;155(5):766-767. doi: 10.1093/ajcp/aqaa271.
引用本文的文献
1
COVID-19 management in patients with comorbid conditions.合并症患者的 COVID-19 管理。
World J Virol. 2025 Jun 25;14(2):102674. doi: 10.5501/wjv.v14.i2.102674.
2
Vitamin D and COVID-19: Clinical Evidence and Immunological Insights.维生素D与2019冠状病毒病：临床证据与免疫学见解。
Life (Basel). 2025 Apr 30;15(5):733. doi: 10.3390/life15050733.
3
Vitamin D deficiency and duration of COVID-19 symptoms in UK healthcare workers.英国医护人员的维生素D缺乏与新冠症状持续时间
Front Med (Lausanne). 2024 Nov 25;11:1494129. doi: 10.3389/fmed.2024.1494129. eCollection 2024.
4
Association of air pollution and weather conditions during infection course with COVID-19 case fatality rate in the United Kingdom.英国感染过程中空气污染和天气条件与 COVID-19 病死率的关联。
Sci Rep. 2024 Jan 6;14(1):683. doi: 10.1038/s41598-023-50474-w.
5
Small molecule metabolites: discovery of biomarkers and therapeutic targets.小分子代谢物：生物标志物和治疗靶点的发现。
Signal Transduct Target Ther. 2023 Mar 20;8(1):132. doi: 10.1038/s41392-023-01399-3.
6
Vitamin D3 Supplementation at 5000 IU Daily for the Prevention of Influenza-like Illness in Healthcare Workers: A Pragmatic Randomized Clinical Trial.每日补充 5000IU 维生素 D3 以预防医护人员患流感样疾病：一项实用随机临床试验。
Nutrients. 2022 Dec 30;15(1):180. doi: 10.3390/nu15010180.
7
Vitamin D insufficiency is high in Malaysia: A systematic review and meta-analysis of studies on vitamin D status in Malaysia.马来西亚维生素D缺乏情况严重：一项关于马来西亚维生素D状况研究的系统评价与荟萃分析
Front Nutr. 2022 Nov 18;9:1050745. doi: 10.3389/fnut.2022.1050745. eCollection 2022.
8
Novel CYP11A1-Derived Vitamin D and Lumisterol Biometabolites for the Management of COVID-19.新型 CYP11A1 衍生维生素 D 和 Lumisterol 生物代谢物可用于治疗 COVID-19。
Nutrients. 2022 Nov 11;14(22):4779. doi: 10.3390/nu14224779.
9
The effect of and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial.补充[具体物质]和维生素D3对COVID-19患者临床结局的影响：一项随机对照临床试验。 （注：原文中“of”后面缺少具体物质名称）
Front Pharmacol. 2022 Nov 8;13:1011522. doi: 10.3389/fphar.2022.1011522. eCollection 2022.
10
Therapeutic advances in COVID-19.《COVID-19 的治疗进展》
Nat Rev Nephrol. 2023 Jan;19(1):38-52. doi: 10.1038/s41581-022-00642-4. Epub 2022 Oct 17.
本文引用的文献
1
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.COVID-19 重症患者的白细胞介素 6 受体拮抗剂。
N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.
2
Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.一项随机临床试验：单次高剂量维生素 D3 对中重度 COVID-19 患者住院时间的影响。
JAMA. 2021 Mar 16;325(11):1053-1060. doi: 10.1001/jama.2020.26848.
3
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.巴尼韦单抗单药或联合埃特司韦单抗治疗轻中度 COVID-19 患者对病毒载量的影响：一项随机临床试验。
JAMA. 2021 Feb 16;325(7):632-644. doi: 10.1001/jama.2021.0202.
4
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.Covid-19 住院患者的中和单克隆抗体。
N Engl J Med. 2021 Mar 11;384(10):905-914. doi: 10.1056/NEJMoa2033130. Epub 2020 Dec 22.
5
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.托珠单抗治疗新冠肺炎合并肺炎住院患者的疗效。
N Engl J Med. 2021 Jan 7;384(1):20-30. doi: 10.1056/NEJMoa2030340. Epub 2020 Dec 17.
6
Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial.维生素 D 补充、ω-3 脂肪酸补充或力量训练对老年人临床结局的影响：DO-HEALTH 随机临床试验。
JAMA. 2020 Nov 10;324(18):1855-1868. doi: 10.1001/jama.2020.16909.
7
Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.长期补充维生素 D3 与安慰剂相比对抑郁或有临床意义的抑郁症状风险的影响，以及对情绪评分变化的影响：一项随机临床试验。
JAMA. 2020 Aug 4;324(5):471-480. doi: 10.1001/jama.2020.10224.
8
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
9
Role of vitamin D in preventing of COVID-19 infection, progression and severity.维生素 D 在预防 COVID-19 感染、进展和严重程度中的作用。
J Infect Public Health. 2020 Oct;13(10):1373-1380. doi: 10.1016/j.jiph.2020.06.021. Epub 2020 Jun 20.
10
Early High-Dose Vitamin D for Critically Ill, Vitamin D-Deficient Patients.危重症、维生素 D 缺乏患者的早期高剂量维生素 D 治疗。
N Engl J Med. 2019 Dec 26;381(26):2529-2540. doi: 10.1056/NEJMoa1911124. Epub 2019 Dec 11.
Zotero 插件